Angiotensin-Converting Enzyme Inhibitors and Diuretics: Optimal Combination Therapy

  1. Barry R. Davis, MD, PhD;
  2. Curt D. Furberg, MD, PhD;
  3. Jackson T. Wright, Jr., MD, PhD;
  4. Jeffrey A. Cutler, MD, MPH; and
  5. Paul Whelton, MD, MSc
  1. From The University of Texas School of Public Health at Houston, Houston, TX 77030; Wake Forest University School of Medicine, Winston-Salem, NC 27157; Case Western Reserve University, Cleveland, OH 44106; National Heart, Lung, and Blood Institute, Bethesda, MD 20892; and Tulane University Health Sciences Center, New Orleans, LA 70112.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. …

    « Previous | Next Article »Table of Contents